JPH0585526B2 - - Google Patents

Info

Publication number
JPH0585526B2
JPH0585526B2 JP57210240A JP21024082A JPH0585526B2 JP H0585526 B2 JPH0585526 B2 JP H0585526B2 JP 57210240 A JP57210240 A JP 57210240A JP 21024082 A JP21024082 A JP 21024082A JP H0585526 B2 JPH0585526 B2 JP H0585526B2
Authority
JP
Japan
Prior art keywords
hbsag
hours
hepatitis
buffer
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57210240A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59101426A (ja
Inventor
Takao Oomura
Terufumi Fujiwara
Akimasa Oomizu
Satoru Funakoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Priority to JP57210240A priority Critical patent/JPS59101426A/ja
Priority to US06/552,079 priority patent/US4565697A/en
Priority to DE8383111821T priority patent/DE3377972D1/de
Priority to EP83111821A priority patent/EP0112506B1/en
Priority to CA000442088A priority patent/CA1217138A/en
Priority to ES527588A priority patent/ES527588A0/es
Publication of JPS59101426A publication Critical patent/JPS59101426A/ja
Publication of JPH0585526B2 publication Critical patent/JPH0585526B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP57210240A 1982-11-29 1982-11-29 Ｂ型肝炎感染予防用ワクチンの製造方法 Granted JPS59101426A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP57210240A JPS59101426A (ja) 1982-11-29 1982-11-29 Ｂ型肝炎感染予防用ワクチンの製造方法
US06/552,079 US4565697A (en) 1982-11-29 1983-11-15 Process for producing a hepatitis B infection preventing vaccine
DE8383111821T DE3377972D1 (en) 1982-11-29 1983-11-25 A process for producing a hepatitis b infection preventing vaccine
EP83111821A EP0112506B1 (en) 1982-11-29 1983-11-25 A process for producing a hepatitis b infection preventing vaccine
CA000442088A CA1217138A (en) 1982-11-29 1983-11-28 Process for producing a hepatitis b infection preventing vaccine
ES527588A ES527588A0 (es) 1982-11-29 1983-11-28 Un procedimiento para producir una vacuna que previene la infeccion de hepatitis b

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57210240A JPS59101426A (ja) 1982-11-29 1982-11-29 Ｂ型肝炎感染予防用ワクチンの製造方法

Publications (2)

Publication Number Publication Date
JPS59101426A JPS59101426A (ja) 1984-06-12
JPH0585526B2 true JPH0585526B2 (en, 2012) 1993-12-07

Family

ID=16586097

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57210240A Granted JPS59101426A (ja) 1982-11-29 1982-11-29 Ｂ型肝炎感染予防用ワクチンの製造方法

Country Status (6)

Country Link
US (1) US4565697A (en, 2012)
EP (1) EP0112506B1 (en, 2012)
JP (1) JPS59101426A (en, 2012)
CA (1) CA1217138A (en, 2012)
DE (1) DE3377972D1 (en, 2012)
ES (1) ES527588A0 (en, 2012)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60193925A (ja) * 1984-03-13 1985-10-02 Chemo Sero Therapeut Res Inst 凍結乾燥製剤化ワクチン
US4695454A (en) * 1985-04-01 1987-09-22 New York Blood Center, Inc. Process for preparing hepatitis B surface antigen containing particles in novel forms which are highly immunogenic
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
JPH0780785B2 (ja) * 1985-07-19 1995-08-30 株式会社ミドリ十字 Ｂ型肝炎ワクチンの製造方法
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
RU1389060C (ru) * 1986-08-13 1993-06-30 Институт иммунологии Способ получени рекомбинатной вакцины к гепатиту В
US4883865A (en) * 1987-09-30 1989-11-28 Merck & Co. Inc. Recovery of pres2+s antigen
CU22290A1 (es) * 1990-10-08 1995-01-31 Cigb Procedimiento para la obtencion de antigeno de superficie del virus de la hepatitis b de superior capacidad inmunoganica y su uso en un preparado vacunal
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells
US5709995A (en) * 1994-03-17 1998-01-20 The Scripps Research Institute Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
US5543129A (en) * 1994-11-17 1996-08-06 Mg Industries Non-cryogenic method and apparatus for producing pure nitrogen
CN109134620A (zh) * 2018-09-21 2019-01-04 中国科学院过程工程研究所 一种纯化HBc-VLPs或HBc-VLPs衍生物的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3100737A (en) * 1958-02-05 1963-08-13 Auerswald Wilhelm Method of preparing a plasma protein solution free of active hepatitis virus and product produced thereby
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US3994870A (en) * 1974-01-31 1976-11-30 The Community Blood Council Of Greater New York, Inc. Purification of hepatitis B surface antigen
JPS5417002B2 (en, 2012) * 1974-02-18 1979-06-27
DE2611723C3 (de) * 1976-03-19 1978-09-21 The Green Cross Corp., Osaka (Japan) Verfahren zur Herstellung von einheitlichen kugelförmigen HBsAg-Teilchen
US4057628A (en) * 1976-04-19 1977-11-08 William L. Wilson Removal of hepatitis associated antigen from plasma
JPS5840930B2 (ja) * 1976-09-20 1983-09-08 株式会社ミドリ十字 Ｂ型肝炎ワクチンの製造方法
US4162192A (en) * 1978-09-28 1979-07-24 Juridical Foundation Method for purification of HBs antigen
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus
US4349539A (en) * 1980-08-15 1982-09-14 Merck & Co., Inc. Separation of hepatitis B surface antigen
US4314997A (en) * 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
DE3043857A1 (de) * 1980-11-21 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ii und vii

Also Published As

Publication number Publication date
EP0112506A3 (en) 1985-05-22
ES8505820A1 (es) 1985-06-16
EP0112506A2 (en) 1984-07-04
EP0112506B1 (en) 1988-09-14
DE3377972D1 (en) 1988-10-20
ES527588A0 (es) 1985-06-16
CA1217138A (en) 1987-01-27
US4565697A (en) 1986-01-21
JPS59101426A (ja) 1984-06-12

Similar Documents

Publication Publication Date Title
US4113712A (en) HBsAG Particle composed of single polypeptide subunits and the preparation procedure
JP3145696B2 (ja) 分泌型免疫グロブリンａ製剤の製造法
JPH0585526B2 (en, 2012)
JPS61280438A (ja) Ｂ型肝炎表面抗原の改良単離精製法
JPS63183539A (ja) 静注用免疫グロブリン製剤の製造方法
JPH0331691B2 (en, 2012)
JPH06321994A (ja) アンチトロンビン調製物およびその調製方法
EP0885241B1 (en) Purification method
US4087519A (en) Medicament for the treatment of hepatitis and/or acute or chronic infections due to the virus of hepatitis B
JPS6078999A (ja) ＨＢｓ抗原の精製方法
WO1981000050A1 (en) Process for producing hepatitis b vaccine
PL182103B1 (pl) Sposób oczyszczania powierzchniowego antygenu wirusa Hepatitis B zawierajacego peptyd preS2 oraz szczepionka przeciw wirusowi Hepatitis B PL PL PL
EP0005864A1 (en) Antigenic composition useful as a vaccine or vaccine intermediate, and process for preparing same
EP0179485B1 (en) A process for the purification of hbsag
KR830000366B1 (ko) B형 간염 감염 예방용 왁찐의 제조방법
JPS63239234A (ja) ワクチン製剤
JP2618643B2 (ja) 静注用免疫グロブリン製剤
JPS6212238B2 (en, 2012)
JP2721961B2 (ja) 血液製剤
JP2775097B2 (ja) 静注用免疫グロブリン製剤
JPS60258127A (ja) Ｂ型肝炎ワクチンの製造方法
JP4105249B2 (ja) α２プラスミンインヒビターの製造方法
JPS5840930B2 (ja) Ｂ型肝炎ワクチンの製造方法
JPS6212239B2 (en, 2012)
JPH0723319B2 (ja) 血液製剤から血液型抗体を除去する方法